Evenity fda approval date?

See the DrugPatentWatch profile for Evenity

When did FDA approve Evenity (romosozumab)?

Evenity (romosozumab-aqqg) received FDA approval on April 9, 2019. [1]

What was Evenity approved for at the time?

FDA approved Evenity to treat osteoporosis in postmenopausal women at high risk for fracture, including those with a history of osteoporotic fracture or multiple risk factors for fracture. [1]

Where can I verify the approval date?

You can cross-check the FDA approval date using the DrugPatentWatch.com page for Evenity. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/evenity